Neodocs

Neodocs

Private
Mumbai, MaharashtraHealthcare & Life Scienceshttps://neodocs.in

Last Round

Seed

Feb 8, 2024

Total Funding Raised

$2M

Momentum Score

25 /100

Company Overview

Neodocs is a health technology company that provides smartphone-based medical testing solutions. The company develops at-home test kits that allow users to perform various diagnostic tests, such as urine and blood analysis, and receive instant results on their mobile devices. The platform tracks over 20 biomarkers for conditions related to kidney health, urinary tract infections (UTIs), and ovulation, among others. Founded in 2020 by Nikunj Malpani, Anurag Meena, and Pratik Lodha, Neodocs aims to make healthcare diagnostics more accessible, affordable, and immediate, eliminating the typical waiting period for lab results. The company partners with pharmaceutical firms, doctors, and government bodies to deploy its technology, particularly in remote areas. In February 2024, Neodocs raised $2 million in a seed funding round to expand its product offerings and enter international markets.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Telemedicine, Computer Vision, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Subscription SaaS

AI Layer

Application

Keywords

at-home testingsmartphone diagnosticsdiagnostic appAI diagnosticspoint-of-care testingcomputer vision diagnosticsremote health monitoringurine testkidney function testsperm count testovulation testdigital diagnosticshealth techwellness cardshealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neodocs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neodocs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 8, 2024
Pre SeedAug 25, 2021
Pre SeedDec 2, 2020

Key People

Founding team and executive leadership

Nikunj Malpani

Co-Founder CEO

Founding Team

Neodocs Investors

Notable investors and investment history

InvestorRounds
Omidyar Network IndiaSeed
Titan CapitalSeed
Titan CapitalSeed, Pre Seed
Y CombinatorSeed, Pre Seed
Prophetic VenturesPre Seed
100UnicornsSeed, Pre Seed
Gemba CapitalPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Active projects and partners named in Philippines, Indonesia, Sri Lanka, Cameroon, and Nepal.

  • Oct 1, 2025

    Company has conducted over 250,000 tests.

Neodocs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neodocs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neodocs's valuation, stock price, and market status.

Firmographic Details

HeadquartersMumbai, Maharashtra
Employee Range49
Year Founded2020
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.